The tiger mosquito is one of the vectors of dengue fever. Image from WikiImages | Pixabay
The tiger mosquito is one of the vectors of dengue fever. Image from WikiImages | Pixabay - Unisanté (University of Lausanne) has conducted a clinical study on a new type of vaccine that induces cellular immunity to combat dengue fever. The results have just been published in The Lancet eBioMedicine. They are positive and encourage further investigation. This approach is also promising for other diseases. A global public health priority. Global warming and urbanization facilitate the spread of the tiger mosquito, responsible for dengue fever.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
